Hamden, CT, United States of America

Holia Hatoum-Mokdad

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 10.3

ph-index = 6

Forward Citations = 142(Granted Patents)


Company Filing History:


Years Active: 2003-2009

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Holia Hatoum-Mokdad: Innovator in Cancer Treatment

Introduction

Holia Hatoum-Mokdad is a prominent inventor based in Hamden, CT (US), known for her significant contributions to the field of cancer treatment. With a total of 11 patents to her name, she has made remarkable strides in developing innovative therapeutic methods.

Latest Patents

Her latest patents include groundbreaking work on the inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas. This invention focuses on methods of treating tumors mediated by RAF kinase, utilizing substituted urea compounds. Additionally, she has developed novel benzofuran and benzothiophene derivatives that are useful in the treatment of hyper-proliferative disorders. These compounds represent a significant advancement in the fight against various cancers.

Career Highlights

Throughout her career, Holia has worked with notable companies such as Bayer Pharmaceuticals Corporation and Bayer Healthcare LLC. Her experience in these leading organizations has allowed her to refine her expertise and contribute to important research in the pharmaceutical industry.

Collaborations

Holia has collaborated with esteemed colleagues, including Jacques P. Dumas and Uday R. Khire, further enhancing her research and development efforts in the field of oncology.

Conclusion

Holia Hatoum-Mokdad's innovative work and dedication to cancer treatment exemplify her role as a leading inventor in the pharmaceutical industry. Her contributions continue to pave the way for advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…